paraproteinemias
Showing 1 - 11 of 11
Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)
Not yet recruiting
- Multiple Myeloma
- +8 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Oct 13, 2022
Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- +7 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Oct 11, 2022
Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)
Active, not recruiting
- Multiple Myeloma
- +19 more
- CYNK-001
-
Denver, Colorado
- +8 more
May 24, 2022
Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
- +7 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Mar 4, 2022
Comprehensive Frailty Assessment
Completed
- Myeloma, Multiple
- +2 more
-
Columbus, OhioThe Ohio State University Hospital East
Feb 27, 2018
Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
Withdrawn
- Amyloidosis
- +2 more
- Amyloidosis
- Cardiac Amyloidosis
-
Cincinnati, OhioUniversity of Cincinnati
Oct 24, 2017
Leukemia, Lymphoma, Paraproteinemias Trial in St. Louis (USCOM scan, Fluid Bolus)
Completed
- Leukemia
- +4 more
- USCOM scan
- Fluid Bolus
-
St. Louis, MissouriWashington University School of Medicine
Aug 30, 2013
Demyelinating Diseases, Paraproteinemias Trial run by the NINDS (intravenous immunoglobulin (IVIg))
Completed
- Demyelinating Diseases
- Paraproteinemias
- intravenous immunoglobulin (IVIg)
-
Bethesda, MarylandNational Institute of Neurological Disorders and Stroke (NINDS)
Mar 3, 2008